Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2011

01.01.2011 | Epidemiology

Associations between mammographic density and serum and dietary cholesterol

verfasst von: Ame-Lia Tamburrini, Christy G. Woolcott, Norman F. Boyd, Martin J. Yaffe, Tim Terry, Yutaka Yasui, Charlotte A. Jones, Scott B. Patten, Kerry S. Courneya, Christine M. Friedenreich

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Although high mammographic density is a risk factor for postmenopausal breast cancer, its etiology remains unclear. We examined whether serum and dietary cholesterol, which increase breast cancer risk and are involved in endogenous estrogen formation, were associated with increased mammographic density. We conducted a cross-sectional analysis of 302 healthy, sedentary postmenopausal women, aged 50–74 years, enrolled in the Alberta Physical Activity and Breast Cancer Prevention Trial between 2003 and 2006. In multiple linear regression models, no significant associations were observed between serum lipids and percent density or dense tissue area (Percent density: b (change in square root percent density per unit change in cholesterol level) = −0.06 (95%CI = −0.26 to 0.13); b = 0.06 (95%CI = −0.48 to 0.61); and b = −0.11 (95%CI = −0.33 to 0.10) for total cholesterol, high-, and low-density lipoprotein, respectively; similar results found for dense area). Alcohol consumption modified the association between triglycerides and percent density (>1 drink/day: b = −0.94 (95%CI = −1.79 to −0.10); ≤1 drink/day: b = 0.19 (95%CI = −0.12 to 0.50); and no alcohol consumption: b = 0.15 (95%CI = −0.44 to 0.73). We found no evidence indicating any association between dietary and serum cholesterol levels and mammographic density.
Literatur
1.
Zurück zum Zitat McCormack VA, dos SS I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169CrossRefPubMed McCormack VA, dos SS I (2006) Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15:1159–1169CrossRefPubMed
2.
Zurück zum Zitat Muti P, Rogan E, Cavalieri E (2006) Androgens and estrogens in the etiology and prevention of breast cancer. Nutr Cancer 56:247–252CrossRefPubMed Muti P, Rogan E, Cavalieri E (2006) Androgens and estrogens in the etiology and prevention of breast cancer. Nutr Cancer 56:247–252CrossRefPubMed
3.
Zurück zum Zitat Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P (2008) Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 122:481–485CrossRefPubMed Trichopoulos D, Adami HO, Ekbom A, Hsieh CC, Lagiou P (2008) Early life events and conditions and breast cancer risk: from epidemiology to etiology. Int J Cancer 122:481–485CrossRefPubMed
4.
Zurück zum Zitat Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMed Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616PubMed
5.
Zurück zum Zitat Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361:296–300CrossRefPubMed Cuzick J, Powles T, Veronesi U, Forbes J, Edwards R, Ashley S, Boyle P (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361:296–300CrossRefPubMed
6.
Zurück zum Zitat Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10:201CrossRefPubMed Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10:201CrossRefPubMed
7.
Zurück zum Zitat Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35PubMed Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35PubMed
8.
Zurück zum Zitat Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617–631CrossRefPubMed Armstrong B, Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617–631CrossRefPubMed
9.
Zurück zum Zitat McMichael AJ, Jensen OM, Parkin DM, Zaridze DG (1984) Dietary and endogenous cholesterol and human cancer. Epidemiol Rev 6:192–216PubMed McMichael AJ, Jensen OM, Parkin DM, Zaridze DG (1984) Dietary and endogenous cholesterol and human cancer. Epidemiol Rev 6:192–216PubMed
10.
Zurück zum Zitat Miller WR (1990) Pathways of hormone metabolism in normal and nonneoplastic breast tissue. Ann N Y Acad Sci 586:53–59CrossRefPubMed Miller WR (1990) Pathways of hormone metabolism in normal and nonneoplastic breast tissue. Ann N Y Acad Sci 586:53–59CrossRefPubMed
11.
Zurück zum Zitat Boyd NF, McGuire V (1990) Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 82:460–468CrossRefPubMed Boyd NF, McGuire V (1990) Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst 82:460–468CrossRefPubMed
12.
Zurück zum Zitat Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160CrossRefPubMed Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I (2004) Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96:1152–1160CrossRefPubMed
13.
Zurück zum Zitat Manjer J, Kaaks R, Riboli E, Berglund G (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10:33–42CrossRefPubMed Manjer J, Kaaks R, Riboli E, Berglund G (2001) Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10:33–42CrossRefPubMed
14.
Zurück zum Zitat Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268:19–24CrossRefPubMed Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A (2005) Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem 268:19–24CrossRefPubMed
15.
Zurück zum Zitat Ray G, Husain SA (2001) Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34:71–76CrossRefPubMed Ray G, Husain SA (2001) Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34:71–76CrossRefPubMed
16.
Zurück zum Zitat Boyd NF, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D (1989) Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer 59:766–771PubMed Boyd NF, McGuire V, Fishell E, Kuriov V, Lockwood G, Tritchler D (1989) Plasma lipids in premenopausal women with mammographic dysplasia. Br J Cancer 59:766–771PubMed
17.
Zurück zum Zitat Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F (1989) Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130:14–24PubMed Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F (1989) Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130:14–24PubMed
18.
Zurück zum Zitat Knight JA, Martin LJ, Greenberg CV, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL, Boyd NF (1999) Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 8:123–128PubMed Knight JA, Martin LJ, Greenberg CV, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL, Boyd NF (1999) Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 8:123–128PubMed
19.
Zurück zum Zitat Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9:151–160PubMed Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9:151–160PubMed
20.
Zurück zum Zitat Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006) Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118:1782–1789CrossRefPubMed Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006) Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118:1782–1789CrossRefPubMed
21.
Zurück zum Zitat Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H (2005) Associations of mammographic density with dietary factors in Japanese women. Cancer Epidemiol Biomarkers Prev 14:2877–2880CrossRefPubMed Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H (2005) Associations of mammographic density with dietary factors in Japanese women. Cancer Epidemiol Biomarkers Prev 14:2877–2880CrossRefPubMed
22.
Zurück zum Zitat Nordevang E, Azavedo E, Svane G, Nilsson B, Holm LE (1993) Dietary habits and mammographic patterns in patients with breast cancer. Breast Cancer Res Treat 26:207–215CrossRefPubMed Nordevang E, Azavedo E, Svane G, Nilsson B, Holm LE (1993) Dietary habits and mammographic patterns in patients with breast cancer. Breast Cancer Res Treat 26:207–215CrossRefPubMed
23.
Zurück zum Zitat Sala E, Warren R, Duffy S, Welch A, Luben R, Day N (2000) High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer 83:121–126CrossRefPubMed Sala E, Warren R, Duffy S, Welch A, Luben R, Day N (2000) High risk mammographic parenchymal patterns and diet: a case-control study. Br J Cancer 83:121–126CrossRefPubMed
24.
Zurück zum Zitat Takata Y, Maskarinec G, Park SY, Murphy SP, Wilkens LR, Kolonel LN (2007) Mammographic density and dietary patterns: the multiethnic cohort. Eur J Cancer Prev 16:409–414CrossRefPubMed Takata Y, Maskarinec G, Park SY, Murphy SP, Wilkens LR, Kolonel LN (2007) Mammographic density and dietary patterns: the multiethnic cohort. Eur J Cancer Prev 16:409–414CrossRefPubMed
25.
Zurück zum Zitat Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14:243–250CrossRefPubMed Thomson CA, Arendell LA, Bruhn RL, Maskarinec G, Lopez AM, Wright NC, Moll CE, Aickin M, Chen Z (2007) Pilot study of dietary influences on mammographic density in pre- and postmenopausal Hispanic and non-Hispanic white women. Menopause 14:243–250CrossRefPubMed
26.
Zurück zum Zitat Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, Jones D, Martin LJ, Lockwood G, Tritchler D (1995) Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev 4:727–733PubMed Boyd NF, Connelly P, Byng J, Yaffe M, Draper H, Little L, Jones D, Martin LJ, Lockwood G, Tritchler D (1995) Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev 4:727–733PubMed
27.
Zurück zum Zitat Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G (2001) Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis 11:44–50PubMed Maskarinec G, Lyu LC, Meng L, Theriault A, Ursin G (2001) Determinants of mammographic densities among women of Asian, Native Hawaiian, and Caucasian ancestry. Ethn Dis 11:44–50PubMed
28.
Zurück zum Zitat Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1411–1417CrossRefPubMed Aiello EJ, Tworoger SS, Yasui Y, Stanczyk FZ, Potter J, Ulrich CM, Irwin M, McTiernan A (2005) Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women. Cancer Epidemiol Biomarkers Prev 14:1411–1417CrossRefPubMed
29.
30.
Zurück zum Zitat Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, Terry T, McTiernan A, Brant R, Ballard-Barbash R, Irwin ML, Jones CA, Brar S, Campbell KL et al (2010) Mammographic density change with one year of aerobic exercise among postmenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 19(4):1112–1121CrossRefPubMed Woolcott CG, Courneya KS, Boyd NF, Yaffe MJ, Terry T, McTiernan A, Brant R, Ballard-Barbash R, Irwin ML, Jones CA, Brar S, Campbell KL et al (2010) Mammographic density change with one year of aerobic exercise among postmenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 19(4):1112–1121CrossRefPubMed
31.
Zurück zum Zitat Calgary Laboratory Services (2002) Chemistry manual: Hitachi 747-Serum Cholesterol. 1–14 Calgary Laboratory Services (2002) Chemistry manual: Hitachi 747-Serum Cholesterol. 1–14
32.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
33.
Zurück zum Zitat Csizmadi I, Kahle L, Ullman R, Dawe U, Zimmerman T, Friedenreich CM, Bryant HE, Subar A (2007) Adaptation and evaluation of the National Cancer Institute’s Dietary History Questionnaire and nutrient database for use in Canadian Populations. Public Health Nutr 10:88–96CrossRefPubMed Csizmadi I, Kahle L, Ullman R, Dawe U, Zimmerman T, Friedenreich CM, Bryant HE, Subar A (2007) Adaptation and evaluation of the National Cancer Institute’s Dietary History Questionnaire and nutrient database for use in Canadian Populations. Public Health Nutr 10:88–96CrossRefPubMed
34.
Zurück zum Zitat Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S (2001) Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol 154:1089–1099CrossRefPubMed Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S (2001) Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol 154:1089–1099CrossRefPubMed
35.
Zurück zum Zitat Thompson FE, Subar AF, Brown CC, Smith AF, Sharbaugh CO, Jobe JB, Mittl B, Gibson JT, Ziegler RG (2002) Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J Am Diet Assoc 102:212–225CrossRefPubMed Thompson FE, Subar AF, Brown CC, Smith AF, Sharbaugh CO, Jobe JB, Mittl B, Gibson JT, Ziegler RG (2002) Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation study. J Am Diet Assoc 102:212–225CrossRefPubMed
36.
Zurück zum Zitat National Cancer Institute ARP (2009). Diet*Calc Analysis Program, Version 1.4.3 National Cancer Institute ARP (2009). Diet*Calc Analysis Program, Version 1.4.3
37.
Zurück zum Zitat Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638CrossRefPubMed Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ (1994) The quantitative analysis of mammographic densities. Phys Med Biol 39:1629–1638CrossRefPubMed
38.
Zurück zum Zitat Friedenreich CM, Courneya KS, Neilson HK, Matthews CE, Willis G, Irwin M, Troiano R, Ballard-Barbash R (2006) Reliability and validity of the Past Year Total Physical Activity Questionnaire. Am J Epidemiol 163:959–970CrossRefPubMed Friedenreich CM, Courneya KS, Neilson HK, Matthews CE, Willis G, Irwin M, Troiano R, Ballard-Barbash R (2006) Reliability and validity of the Past Year Total Physical Activity Questionnaire. Am J Epidemiol 163:959–970CrossRefPubMed
39.
Zurück zum Zitat Brisson J, Diorio C, Masse B (2003) Wolfe’s parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications? Cancer Epidemiol Biomarkers Prev 12:728–732 Brisson J, Diorio C, Masse B (2003) Wolfe’s parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications? Cancer Epidemiol Biomarkers Prev 12:728–732
40.
Zurück zum Zitat van der Gaag MS, Sierksma A, Schaafsma G, Van TA, Geelhoed-Mieras T, Bakker M, Hendriks HF (2000) Moderate alcohol consumption and changes in postprandial lipoproteins of premenopausal and postmenopausal women: a diet-controlled, randomized intervention study. J Womens Health Gend Based Med 9:607–616CrossRefPubMed van der Gaag MS, Sierksma A, Schaafsma G, Van TA, Geelhoed-Mieras T, Bakker M, Hendriks HF (2000) Moderate alcohol consumption and changes in postprandial lipoproteins of premenopausal and postmenopausal women: a diet-controlled, randomized intervention study. J Womens Health Gend Based Med 9:607–616CrossRefPubMed
41.
Zurück zum Zitat Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808CrossRefPubMed Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD (2005) Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808CrossRefPubMed
42.
Zurück zum Zitat Katan MB, Beynen AC, de Vries JH, Nobels A (1986) Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 123:221–234PubMed Katan MB, Beynen AC, de Vries JH, Nobels A (1986) Existence of consistent hypo- and hyperresponders to dietary cholesterol in man. Am J Epidemiol 123:221–234PubMed
43.
Zurück zum Zitat Boyd NF, Connelly P, Lynch H, Knaus M, Michal S, Fili M, Martin LJ, Lockwood G, Tritchtler D (1995) Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol Biomarkers Prev 4(2):117–122PubMed Boyd NF, Connelly P, Lynch H, Knaus M, Michal S, Fili M, Martin LJ, Lockwood G, Tritchtler D (1995) Plasma lipids, lipoproteins, and familial breast cancer. Cancer Epidemiol Biomarkers Prev 4(2):117–122PubMed
44.
Zurück zum Zitat Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86:s858–s866PubMed Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr 86:s858–s866PubMed
Metadaten
Titel
Associations between mammographic density and serum and dietary cholesterol
verfasst von
Ame-Lia Tamburrini
Christy G. Woolcott
Norman F. Boyd
Martin J. Yaffe
Tim Terry
Yutaka Yasui
Charlotte A. Jones
Scott B. Patten
Kerry S. Courneya
Christine M. Friedenreich
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0927-7

Weitere Artikel der Ausgabe 1/2011

Breast Cancer Research and Treatment 1/2011 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.